Business
Sam Chun Dang Pharm Co European Medicines Agency Approves Phase I Clinical Study Plan On Oral Insulin In Germany
Sam Chun Dang Pharm Co European Medicines Agency Approves Phase I Clinical Study Plan On Oral Insulin In Germany
About this update from Sam Chun Dang Pharm. Co., Ltd.
Sam Chun Dang Pharm Co Ltd KRX:000250:EUROPEAN MEDICINES AGENCY APPROVES PHASE I CLINICAL STUDY PLAN ON ORAL INSULIN IN GERMANY
View stock analysis, news, and events for Sam Chun Dang Pharm. Co., Ltd.